GLP-1 weight loss clinics help eligible adults access medications such as semaglutide or tirzepatide through in-person or telehealth care. A safe clinic should require a medical review, prescribe only when appropriate, explain FDA-approved versus compounded options, provide follow-up support, and use licensed pharmacies—not sell peptides without a prescription.
Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.
See if you qualify →What is a GLP-1 weight loss clinic?
A GLP-1 weight loss clinic is a medical service that evaluates whether weight-loss medication may be appropriate, then provides prescribing and follow-up when clinically indicated. These clinics may be local, hospital-based, pharmacy-linked, or fully online.
GLP-1 receptor agonists were first developed for glucose control and are now used in obesity care because they help regulate appetite, satiety, gastric emptying, insulin secretion, and glucagon signaling 1. A recent systematic review of 21 randomized trials found GLP-1-based medications increased the likelihood of weight loss versus placebo, with semaglutide and tirzepatide ranking highly among studied agents 2. Individual results vary, and benefits should be weighed with risks such as nausea, vomiting, diarrhea, constipation, gallbladder disease, pancreatitis, and boxed-warning contraindications for medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 1.
How GLP-1 clinics differ from primary care, pharmacies, and med spas
Primary care offices can prescribe GLP-1 medication and may also manage diabetes, blood pressure, cholesterol, and sleep apnea in one place. A pharmacy fills the prescription but does not replace medical screening. A med spa may offer wellness services, but a safe GLP-1 program still needs licensed prescribers, medication review, and a clear plan for side effects.
The FDA advises patients to obtain GLP-1 medications with a prescription from a clinician and fill that prescription through a state-licensed pharmacy 3. A clinic that skips screening, has no clinician available, or sells “research” peptides without a prescription is not a safe medical path.
Online GLP-1 clinics vs local in-person clinics
An online clinic can be convenient if it offers real clinician review, secure messaging, clear instructions, and licensed pharmacy fulfillment. A local clinic may be better if you need a physical exam, complex lab review, injectable teaching in person, or coordination with several specialists.
| Clinic type | Best fit | Watch for |
|---|---|---|
| Online GLP-1 clinic | Convenience, home delivery, ongoing portal messaging, cash-pay compounded options when appropriate | No prescription requirement, unclear pharmacy, no clinician access |
| Primary care clinic | People with diabetes, hypertension, high cholesterol, kidney disease, or several medications | Long wait times, limited medication access, insurance delays |
| Hospital weight-management program | Complex obesity care, bariatric history, eating disorder concerns, severe symptoms | Higher cost, travel, longer intake process |
| Med spa or wellness clinic | May offer coaching or body composition services | Medication access without full medical oversight |
What should you know before choosing a GLP-1 clinic?
The short version: prescription required means prescription required. A good clinic checks your medical history, BMI, current medications, pregnancy status, and contraindications before discussing medication.
- A clinic should explain that FDA-approved and compounded GLP-1 medications are not the same. FDA-approved drugs have FDA-reviewed labeling; compounded drugs are made for a patient under specific legal rules and are not FDA-approved 3.
- A clinic should review contraindications and warnings, including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, pancreatitis concerns, gallbladder disease, pregnancy, and medication interactions 1.
- A clinic should offer follow-up because gastrointestinal side effects are common, and dose changes should be provider-guided rather than self-directed 1.
- A clinic should discuss long-term planning because weight regain can occur after stopping semaglutide, as shown in the STEP 1 extension study 4.
Who may qualify for GLP-1 medication for weight loss?
Eligibility depends on the medication, your health history, your BMI, and the prescriber’s judgment. Many clinics use obesity or overweight with weight-related conditions as a starting point, but the final decision is clinical.
Clinics commonly review BMI, weight history, type 2 diabetes, insulin resistance, PCOS, sleep apnea, hypertension, high cholesterol, kidney or liver history, pregnancy status, prior bariatric surgery, and current medications. Semaglutide 2.4 mg once weekly was studied in adults with overweight or obesity and type 2 diabetes in the STEP 2 randomized trial 5. Liraglutide 3.0 mg once daily was studied in BARI-OPTIMISE for patients with poor weight loss after metabolic surgery 6. These study doses describe research protocols, not instructions for a reader.
Some people need in-person care rather than a simple telehealth start. Examples include severe abdominal symptoms, active eating disorder concerns, pregnancy or trying to become pregnant, complex diabetes medication use, prior pancreatitis, severe kidney disease, or unclear medication safety.
Which GLP-1 medications do weight loss clinics commonly discuss?
Clinics often discuss semaglutide, tirzepatide, and liraglutide. These medicines are related, but they are not identical, and compounded versions should not be described as the same as brand-name products.
Semaglutide: Wegovy, Ozempic, and compounded semaglutide
Semaglutide is a GLP-1 receptor agonist. Wegovy is a semaglutide product with a weight-management indication; Ozempic is a semaglutide product used for type 2 diabetes; compounded semaglutide via a 503A pharmacy may be discussed by some clinics for certain patient needs. In the STEP 2 trial, semaglutide 2.4 mg once weekly was studied in adults with overweight or obesity and type 2 diabetes 5. Gastrointestinal side effects and contraindications still matter, and outcomes for compounded formulations are not established through FDA review 3.
If you are comparing semaglutide access, our guides to buying semaglutide safely, semaglutide injections online, and the best price for compounded semaglutide explain prescription and pharmacy questions in more detail.
Tirzepatide: Zepbound, Mounjaro, and compounded tirzepatide
Tirzepatide is a GIP/GLP-1 receptor agonist, meaning it acts on glucose-dependent insulinotropic polypeptide and GLP-1 pathways. Zepbound is a tirzepatide product with a weight-management indication; Mounjaro is a tirzepatide product used for type 2 diabetes; compounded tirzepatide via a 503A pharmacy is a separate compounded medication path. A systematic review found tirzepatide and semaglutide ranked highest among evaluated GLP-1-based agents for weight-loss likelihood, but side effects and contraindications remain part of the risk-benefit discussion 2.
For more detail, see our guides on buying tirzepatide safely online, tirzepatide injections online, and microdosing tirzepatide near you.
Liraglutide: Saxenda and other older GLP-1 options
Liraglutide is an older GLP-1 receptor agonist. Saxenda is a liraglutide product used for weight management, and Victoza is a liraglutide product used for type 2 diabetes. In BARI-OPTIMISE, liraglutide 3.0 mg once daily was studied against placebo in patients with poor weight loss after metabolic surgery 6. Like other GLP-1 medicines, liraglutide can cause gastrointestinal side effects and needs clinician oversight.
| Medication | Drug class | Common brand examples | Clinic discussion points |
|---|---|---|---|
| Semaglutide | GLP-1 receptor agonist | Wegovy, Ozempic | Evidence base, injection schedule, side effects, contraindications, FDA-approved vs compounded path |
| Tirzepatide | GIP/GLP-1 receptor agonist | Zepbound, Mounjaro | Dual incretin mechanism, cost, access, side effects, compounded tablet or injection availability at some clinics |
| Liraglutide | GLP-1 receptor agonist | Saxenda, Victoza | Older option, daily injection in studied products, tolerability, coverage |
How do GLP-1 medications support weight loss?
GLP-1 medications help with weight management by changing hunger and fullness signals. They also affect gastric emptying and glucose hormones, which is why clinicians review diabetes status and other medications carefully.
The main pathways are appetite regulation, increased satiety, slower gastric emptying, insulin secretion when glucose is elevated, and reduced glucagon signaling 1. These effects can make it easier to eat less, but medication is not the whole plan. Protein intake, resistance training, sleep, and a realistic calorie pattern still matter, especially because some weight loss can include lean body mass 1.
Stopping treatment can lead to regain. In the STEP 1 extension, participants regained weight and lost some cardiometabolic improvements after semaglutide withdrawal 4. That is why a good clinic should talk about maintenance, tapering or stopping plans when appropriate, nutrition, and strength training—not just the first prescription.
3-min quiz
Considering online GLP-1 care?
Chia offers online clinician evaluation for compounded semaglutide injection and compounded tirzepatide tablets or injection when clinically appropriate. A prescription requires review by a licensed US provider and is not guaranteed. Compounded drugs are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality before marketing.
How should you compare GLP-1 weight loss clinics?
Compare clinics on medical safety first, then cost and convenience. The safest-looking price is not always the lowest total cost if follow-up, supplies, shipping, or clinician access are missing.
| What to compare | What a strong clinic includes | Red flag |
|---|---|---|
| Prescription process | Licensed clinician reviews health history, BMI, medications, contraindications, and goals | Medication sold without screening or prescription |
| Pharmacy | State-licensed pharmacy; clear medication labeling and instructions | No pharmacy name, damaged packaging, unclear source |
| Medication claims | Explains FDA-approved and compounded options without calling them identical | Says compounded medication is the same as Wegovy, Ozempic, Zepbound, or Mounjaro |
| Follow-up | Access for side effects, dose questions, and long-term planning | No clinician available after purchase |
| Pricing | Clear monthly cost, refill process, supplies, shipping, and visit fees | Deep discounts that seem too good to be true |
| Lifestyle support | Nutrition, protein, strength training, and maintenance planning | Medication-only quick-fix messaging |
| When to refer | Refers to in-person care for urgent symptoms or complex cases | Handles severe symptoms only by chat or ignores them |
The FDA lists telehealth red flags, including no licensed doctor screening, no prescription, no doctor available for questions, claims that compounded drugs are the same as FDA-approved drugs, and prices that seem too good to be true 3. Those are practical checks to use before paying.
How much do GLP-1 weight loss clinics cost?
GLP-1 clinic cost can include the consult, membership, medication, supplies, labs, shipping, and follow-up. Insurance may lower cost for some brand-name products, but coverage varies widely.
Affordability is a major barrier to GLP-1 obesity medications in the US, and policy experts have noted that broad access is difficult because many adults may be eligible and medication costs can be high 7. Access reviews also describe how compounded GLP-1 medications emerged partly because brand-name cost and coverage gaps left some patients without practical options 8.
- Consult-only model: you pay for the visit, and medication is billed separately through a pharmacy.
- Membership model: you pay a recurring fee that may include visits, messaging, and care coordination.
- Medication-included model: you pay one monthly price for medication plus some care services.
- Insurance-based model: your clinician sends a prescription and your insurance plan decides coverage, prior authorization, and copay.
Ask what is included before you pay: clinician visits, refills, needles or supplies if injectable, shipping, side-effect support, dose-change visits, labs if needed, and cancellation rules.
How does GLP-1 treatment at Chia work online?
At Chia, we offer a 100% online path for eligible patients seeking compounded GLP-1 treatment. Our licensed US providers review a health questionnaire and prescribe only when clinically appropriate.
Chia offers compounded semaglutide injection, with plans currently starting at $249/month, and microdosing plans available. Chia also offers compounded tirzepatide tablets or injection: tablets currently start at $249/month, injections currently start at $299/month, and microdosing plans are available. Dosing is provider-guided and adjusted over time; patients can message the care team through the patient portal.
| Chia option | Forms listed in Chia catalog | Current starting price | Notes |
|---|---|---|---|
| Semaglutide | Injection | From $249/month | Compounded by US state-licensed 503A pharmacies; microdosing plans available |
| Tirzepatide | Tablets or injection | Tablets from $249/month; injection from $299/month | Compounded by US state-licensed 503A pharmacies; microdosing plans available |
| Weight + Energy | NAD+ injection + choice of GLP-1 | From $309/month | Protocol option for eligible patients; see Weight + Energy |
| Weight + Muscle | Sermorelin injection + choice of GLP-1 | From $329/month | Protocol option for eligible patients; see Weight + Muscle |
All Chia medications listed here are compounded in the US by state-licensed 503A compounding pharmacies and shipped to the patient’s door. Patients can start with Chia’s online quiz, and where it directly fits their workflow, Chia can also be reached by AI agents through DoctorMCP at mcp.chia.health.
Are online GLP-1 clinics safe?
Online GLP-1 clinics can be safe when they use licensed clinicians, real prescriptions, state-licensed pharmacies, and ongoing follow-up. The risk rises when a site sells medication without a prescription or hides where the medication comes from.
The FDA states that unapproved GLP-1 drugs do not undergo FDA review for safety, effectiveness, or quality before marketing 3. The FDA also recommends that compounded drugs be used only when a patient’s medical needs cannot be met by an FDA-approved drug, and that prescriptions be filled through a state-licensed pharmacy 3.
Safety is not just the vial, pen, tablet, or shipment. It is the whole system: screening, contraindication review, medication reconciliation, clear instructions, side-effect support, refill timing, and a plan for urgent symptoms.
What should a good GLP-1 clinic include after you start?
A good GLP-1 clinic should stay involved after the first prescription. Follow-up helps manage side effects, adjust treatment safely, and protect muscle and long-term health.
- Ongoing check-ins for nausea, vomiting, diarrhea, constipation, reflux, appetite changes, hydration, and medication questions.
- Provider-guided dose decisions rather than patient-led dose changes.
- Clear instructions for when to seek care, especially for severe abdominal pain, persistent vomiting, dehydration, allergic reaction, or signs of gallbladder problems.
- Nutrition support that emphasizes enough protein, fiber, fluids, and regular meals when appetite is low.
- Strength training guidance to help preserve lean body mass during weight loss.
- A long-term plan for maintenance, continuing treatment, switching treatment, or stopping when clinically appropriate.
This long-term view matters because GLP-1 treatment is not a quick reset. Reviews note meaningful weight loss with these medications, but also gastrointestinal side effects, rare serious risks, possible lean body mass loss, and weight regain after discontinuation 1.
3-min quiz
Start with a clinician-reviewed path
If you are comparing GLP-1 weight loss clinics, Chia can help you see whether online care may fit. A licensed US provider reviews your health history and prescribes only when clinically appropriate; treatment is not guaranteed. You can also read more about semaglutide, tirzepatide, and Chia’s GLP-1 protocol options before starting.
Frequently asked questions about GLP-1 weight loss clinics
You can get a GLP-1 medication through a licensed clinician if it is medically appropriate. Options may include primary care, an obesity medicine clinic, a hospital weight-management program, or a telehealth clinic that requires screening and uses licensed pharmacies.
The cheapest program depends on insurance, consult fees, medication cost, shipping, supplies, labs, and follow-up. A very low advertised price may not be the lowest total cost if it excludes clinician access or uses an unclear pharmacy.
The best provider for you is one that reviews your full health history, explains medication options clearly, uses licensed pharmacies, offers follow-up, and refers you to in-person care when needed. No single clinic is best for everyone.
Yes, telehealth clinicians can prescribe GLP-1 medication when they are licensed to treat you and determine it is clinically appropriate. A prescription is not guaranteed and should follow a real medical review.
No. Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality before marketing. They also should not be described as identical to brand-name GLP-1 drugs.
Sometimes. Lab needs depend on your health history, medications, diabetes status, kidney or liver history, symptoms, and clinician judgment. Some patients can be evaluated with history and vitals; others need lab testing or in-person care.
Tell the clinic before starting. These conditions may affect eligibility, medication choice, monitoring, and whether your GLP-1 care should be coordinated with your primary care clinician or specialist.
Often, yes, but the new clinician should review your prior medication, dose history, side effects, health changes, pharmacy records when available, and current goals before deciding whether to continue or change treatment.
References
- 1.Weight Reduction with GLP-1 Agonists and Paths for Future Development. 2025.
- 2.GLP-1 receptor agonists for weight loss: A systematic review and meta-analysis. 2026.
- 3.U.S. Food and Drug Administration. FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. 2026.
- 4.Wilding JPH, Batterham RL, Davies M, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes, Obesity & Metabolism. 2022.
- 5.Davies M, Færch L, Jeppesen OK, et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. Lancet. 2021.
- 6.Mok J, Adeleke MO, Brown A, et al. Safety and Efficacy of Liraglutide, 3.0 mg, Once Daily vs Placebo in Patients With Poor Weight Loss Following Metabolic Surgery: The BARI-OPTIMISE Randomized Clinical Trial. JAMA Surgery. 2023.
- 7.Affordable access to GLP-1 obesity medications. 2026.
- 8.Navigating Access: The Future of Compounded GLP-1 Receptor Agonists. 2026.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
See if GLP-1 is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.
